Defining exercise prescription in lifestyle modification programs for overweight/obese polycystic ovary syndrome women

28 11 2011

To the Editor:

We reviewed the manuscript by Nybacka et al. (1) with great interest. The authors randomized overweight/obese women with polycystic ovary syndrome (PCOS) to investigate the effects of different lifestyle modification approaches on ovarian function and endocrine/metabolic parameters. The patients were assigned to diet, exercise or diet plus exercise for 4 months, and at least 1-year after the termination of the programs were invited to participate in a follow-up visit. A total of 14, 17 and 12 women completed, respectively, the diet, exercise and diet plus exercise intervention after 4 months, and 7 of each group completed the follow-up visit. At the end of the study the authors’ conclusion was that “properly managed diet and exercise, alone or in combination, are equally effective in improving reproductive function in overweight/obese women with PCOS, despite the minor weight loss associated with exercise.” Read the rest of this entry »


PCOS is common in patients undergoing bariatric surgery in a British center

20 04 2010

To the Editor:

We read with great interest the article by Gosman et al (1). The authors highlight that 13.1% of female patients undergoing bariatric surgery had already been diagnosed with PCOS by a health care provider. Data on the incidence of polycystic ovary syndrome (PCOS) in this population from outside the U.S. and the U.K. in particular are limited. Read the rest of this entry »

Comment on “Body mass index is an independent risk factor for the development of endometrial polyps in patients undergoing in vitro fertilization.”

4 03 2009

To the Editor:

We would like to make some comments on the paper by Onalan et al (1). In this paper, the authors found that obesity could be a factor in initiating the growth of an endometrial polyp because they identified obesity as the only independent risk factor using logistic regression analysis. Read the rest of this entry »

Effect of sibutramine on weight reduction in women with polycystic ovary syndrome:a randomized, double-blind, placebo-controlled trial

30 10 2008



To the Editor:



We have read with great interest the well-designed study by Lindholm et al. (1) and we would like to comment on the potential relationship between weight reduction and insulin resistance (IR) in women with polycystic ovary syndrome (PCOS) treated with sibutramine. Read the rest of this entry »